Total Payments
$8,231
2024 Payments
$2,302
Companies
40
Transactions
395
Medicare Patients
2,255
Medicare Billing
$91,959
Payment Breakdown by Category
Food & Beverage$8,172 (99.3%)
Education$58.70 (0.7%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,172 | 393 | 99.3% |
| Education | $58.70 | 2 | 0.7% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $987.35 | 59 | $0 (2024) |
| Amgen Inc. | $919.37 | 36 | $0 (2024) |
| Lilly USA, LLC | $894.65 | 41 | $0 (2024) |
| Dexcom, Inc. | $530.10 | 26 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $521.75 | 17 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $428.62 | 23 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $414.81 | 19 | $0 (2024) |
| Abbott Laboratories | $406.25 | 22 | $0 (2024) |
| Xeris Pharmaceuticals, Inc. | $351.21 | 18 | $0 (2024) |
| Corcept Therapeutics | $304.16 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $2,302 | 104 | Amgen Inc. ($350.10) |
| 2023 | $2,277 | 109 | Amgen Inc. ($334.33) |
| 2022 | $2,302 | 114 | Novo Nordisk Inc ($271.98) |
| 2021 | $1,350 | 68 | Novo Nordisk Inc ($204.97) |
All Payment Transactions
395 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $25.67 | General |
| Category: Diabetes | ||||||
| 12/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $25.96 | General |
| Category: DIABETES | ||||||
| 12/12/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $22.58 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 12/11/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $25.63 | General |
| Category: Inflammation/Rare Disease | ||||||
| 12/10/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $25.00 | General |
| 12/10/2024 | Amphastar Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $25.00 | General |
| 12/10/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Diabetes Care | ||||||
| 12/04/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $15.33 | General |
| Category: Durable Pump | ||||||
| 12/03/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.78 | General |
| Category: Diabetes | ||||||
| 11/25/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Diabetes Care | ||||||
| 11/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $23.13 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $21.74 | General |
| Category: Endocrinology | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $26.74 | General |
| Category: Diabetes | ||||||
| 11/06/2024 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Durable Pump | ||||||
| 11/06/2024 | ABBVIE INC. | — | Food and Beverage | In-kind items and services | $13.12 | General |
| 11/05/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: Diabetes | ||||||
| 10/31/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.96 | General |
| Category: DIABETES | ||||||
| 10/29/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $15.55 | General |
| Category: Endocrinology | ||||||
| 10/28/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $25.16 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $17.02 | General |
| Category: Diabetes Care | ||||||
| 10/24/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $17.99 | General |
| Category: Inflammation/Rare Disease | ||||||
| 10/23/2024 | Amgen Inc. | EVENITY (Biological), Prolia | Food and Beverage | In-kind items and services | $21.61 | General |
| Category: Bone Health | ||||||
| 10/22/2024 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $11.16 | General |
| Category: Diabetes | ||||||
| 10/18/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Diabetes Care | ||||||
| 10/16/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $26.21 | General |
| Category: Cardiology/Vascular Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 15 | 1,125 | 2,137 | $168,547 | $46,734 |
| 2022 | 16 | 1,130 | 2,006 | $160,370 | $45,225 |
Total Patients
2,255
Total Services
4,143
Medicare Billing
$91,959
Procedure Codes
31
All Medicare Procedures & Services
31 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 138 | 364 | $99,736 | $27,287 | 27.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 129 | 315 | $12,285 | $3,186 | 25.9% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 111 | 188 | $11,656 | $3,051 | 26.2% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 122 | 299 | $10,764 | $2,788 | 25.9% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 132 | 320 | $3,520 | $2,633 | 74.8% |
| 82306 | Vitamin d-3 level | Office | 2023 | 37 | 53 | $5,830 | $1,487 | 25.5% |
| 83721 | Ldl cholesterol level | Office | 2023 | 98 | 129 | $4,515 | $1,291 | 28.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 87 | 94 | $4,700 | $1,210 | 25.7% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 52 | 114 | $3,762 | $1,000 | 26.6% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 12 | 14 | $2,590 | $751.44 | 29.0% |
| 95251 | Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | Office | 2023 | 34 | 40 | $3,680 | $604.15 | 16.4% |
| 84481 | Thyroid hormone, t3 measurement, free | Office | 2023 | 19 | 26 | $1,638 | $431.60 | 26.3% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 66 | 76 | $1,596 | $420.06 | 26.3% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 67 | 77 | $1,463 | $382.10 | 26.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 21 | 28 | $812.00 | $213.08 | 26.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 141 | 339 | $92,886 | $26,988 | 29.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2022 | 128 | 298 | $11,622 | $3,066 | 26.4% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2022 | 105 | 169 | $10,478 | $2,784 | 26.6% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 124 | 273 | $9,828 | $2,581 | 26.3% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 11 | 13 | $4,797 | $1,625 | 33.9% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2022 | 78 | 83 | $4,150 | $1,082 | 26.1% |
| 83721 | Ldl cholesterol level | Office | 2022 | 83 | 101 | $3,535 | $1,027 | 29.1% |
| 82306 | Vitamin d-3 level | Office | 2022 | 29 | 35 | $3,850 | $990.71 | 25.7% |
| 83970 | Parathormone (parathyroid hormone) level | Office | 2022 | 18 | 23 | $3,519 | $936.20 | 26.6% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2022 | 56 | 106 | $3,498 | $933.42 | 26.7% |
About Laurel Zuberi, NP
Laurel Zuberi, NP is a Family healthcare provider based in Portland, Oregon. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/15/2006. The National Provider Identifier (NPI) number assigned to this provider is 1457395311.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Laurel Zuberi, NP has received a total of $8,231 in payments from pharmaceutical and medical device companies, with $2,302 received in 2024. These payments were reported across 395 transactions from 40 companies. The most common payment nature is "Food and Beverage" ($8,172).
As a Medicare-enrolled provider, Zuberi has provided services to 2,255 Medicare beneficiaries, totaling 4,143 services with total Medicare billing of $91,959. Data is available for 2 years (2022–2023), covering 31 distinct procedure/service records.
Ad
Practice Information
- Specialty Family
- Location Portland, OR
- Active Since 06/15/2006
- Last Updated 03/16/2020
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1457395311
Products in Payments
- JARDIANCE (Drug) $947.09
- Dexcom G6 Transmitter (Medical Supply) $490.01
- EVENITY (Biological) $473.02
- Kerendia (Drug) $428.62
- Ozempic (Drug) $382.65
- LEQVIO (Drug) $365.85
- Rybelsus (Drug) $353.41
- Korlym (Drug) $304.16
- FREESTYLE LIBRE 3 (Device) $264.64
- FARXIGA (Drug) $228.76
- GVOKE HYPOPEN (Drug) $224.21
- TEPEZZA (Biological) $204.74
- MOUNJARO (Drug) $195.54
- MINIMED 780G (Device) $143.37
- TEPEZZA (Drug) $126.74
- Prolia (Biological) $125.00
- STRENSIQ (Biological) $124.56
- MYCAPSSA (Drug) $124.15
- Repatha (Biological) $116.61
- Omnia (Device) $116.40
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Portland
Jill Carter, Dnp, Pmhnp, Fnp, DNP, PMHNP, FNP
Family — Payments: $242,853
Family $242,853
Mrs. Rachel Pangilinan, Msn, Fnp-C, MSN, FNP-C
Family — Payments: $58,984
Family $58,984
Alana Wilson, Msn, Fnp-C, MSN, FNP-C
Family — Payments: $56,923
Family $56,923
Lani Doser, Fnp-C, FNP-C
Family — Payments: $37,510
Family $37,510
Susan Tofte, Fnp, FNP
Family — Payments: $25,428
Family $25,428
Meng Lan Cheung Gan, Fnp, FNP
Family — Payments: $7,859
Family $7,859